Relatively high rate of postpartum thyroiditis in the Straits of Messina area. Predictivity of both postpartum thyroiditis and permanent hypothyroidism by performing, in the first trimester of gestation, thyroid ultrasonography and measurement of serum thyroperoxidase and thyroglobulin autoantibodies.
Geoepidemiology
Postpartum thyroiditis
Thyroid autoimmunity
Journal
Journal of clinical & translational endocrinology
ISSN: 2214-6237
Titre abrégé: J Clin Transl Endocrinol
Pays: Netherlands
ID NLM: 101629335
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
04
09
2018
revised:
03
11
2018
accepted:
21
11
2018
entrez:
18
12
2018
pubmed:
18
12
2018
medline:
18
12
2018
Statut:
epublish
Résumé
The prevalence of postpartum thyroiditis (PPT) averages 5%, with a range from 1% (Thailand) to 22% (Wales, UK, and Liguria, Italy), but 3.6% in another Italian region (Puglia). Evolution of PPT into permanent hypothyroidism (PH) occurs in approximately 50% of cases. Positive thyroperoxidase autoantibodies (TPOAb) in a pregnant woman is a strong predictor of PPT. Because in previous gestational cohorts we found an approximate 12% rate of TPOAb positivity, which compares with 15% in the Liguria cohort and 6% in the Puglia cohort, we hypothesized that the currently unknown prevalence of PPT in Sicily would approximate the said Liguria prevalence. We also explored the predictive value of serum thyroglobulin Ab (TgAb) positivity and ultrasonographic signs suggestive of thyroiditis (UST) at first trimester of gestation for PPT. Of 412 pregnant women who were followed-up for 1 year after delivery, 63 (15.3%) developed PPT, and 54% of them had PH. Gestational rates of TPOAb positivity alone, TgAb positivity alone or UST were 11.4%, 7.8% or 35.0%, with associated PPT rates of 66%, 45% or 36%. TgAb assay allowed detection of 9/63 PPT women (14.3%) who were TPOAb-negative. However, TPOAb remained a better predictor compared to TgAb or UST (odds ratio = 32
Identifiants
pubmed: 30555788
doi: 10.1016/j.jcte.2018.11.004
pii: S2214-6237(18)30103-0
pmc: PMC6275208
doi:
Types de publication
Journal Article
Langues
eng
Pagination
12-18Commentaires et corrections
Type : ErratumIn
Références
Clin Endocrinol (Oxf). 2000 Jul;53(1):21-31
pubmed: 10931077
J Endocrinol Invest. 2002 Jun;25(6):513-9
pubmed: 12109622
J Clin Endocrinol Metab. 2007 Apr;92(4):1263-8
pubmed: 17284630
J Clin Endocrinol Metab. 1992 Mar;74(3):645-53
pubmed: 1740500
J Endocrinol Invest. 1991 Sep;14(8):669-74
pubmed: 1774451
Acta Endocrinol (Copenh). 1991 Aug;125(2):146-9
pubmed: 1897331
J Endocrinol Invest. 2008 Dec;31(12):1063-8
pubmed: 19246971
J Clin Endocrinol Metab. 2011 Mar;96(3):652-7
pubmed: 21190974
Autoimmunity. 1990;6(3):211-4
pubmed: 2129779
Thyroid. 2011 Oct;21(10):1081-125
pubmed: 21787128
Psychoneuroendocrinology. 2012 Apr;37(4):519-33
pubmed: 22047958
J Clin Endocrinol Metab. 2012 Feb;97(2):334-42
pubmed: 22312089
Br Med J (Clin Res Ed). 1988 Jan 23;296(6617):241-4
pubmed: 3124900
Acta Med Scand. 1987;222(4):369-74
pubmed: 3425388
Arch Intern Med. 1987 Feb;147(2):221-4
pubmed: 3492979
Arch Intern Med. 1986 Jul;146(7):1361-4
pubmed: 3755021
Ceska Gynekol. 1994 Apr;59(2):56-9
pubmed: 8004369
Acta Endocrinol (Copenh). 1993 Jul;129(1):26-30
pubmed: 8351955
Eur J Endocrinol. 1998 Jul;139(1):36-43
pubmed: 9703376